<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04281121</url>
  </required_header>
  <id_info>
    <org_study_id>MD 44/2017</org_study_id>
    <nct_id>NCT04281121</nct_id>
  </id_info>
  <brief_title>Omega 3 Supplementation in Children With Non Alcoholic Fatty Liver</brief_title>
  <acronym>omega 3</acronym>
  <official_title>the Effect of Omega 3 Fatty Acids Supplements on Antioxidant Capacity in Egyptian Children With Non Alcoholic Fatty Liver Disease</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Ain Shams University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Ain Shams University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      this is a prospective, interventional, open-label, randomized study on the efficacy of omega
      3 fatty acids supplementation in Egyptian children with non-alcoholic fatty liver disease who
      had been selected from nutrition and outpatient clinic at Pediatric hospital, Ain Shams
      University
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">March 1, 2019</start_date>
  <completion_date type="Actual">February 19, 2020</completion_date>
  <primary_completion_date type="Actual">January 25, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>grade of fatty liver in children</measure>
    <time_frame>3 month</time_frame>
    <description>improvement</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">60</enrollment>
  <condition>Fatty Liver</condition>
  <arm_group>
    <arm_group_label>supplemented</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Life style modification, diet regimen and Omega-3 fatty acids supplementation</description>
  </arm_group>
  <arm_group>
    <arm_group_label>non supplemented</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Life style modification and diet regimen</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>omega 3 fatty acids</intervention_name>
    <description>: Life style modification, diet regimen and Omega-3 fatty acids supplementation: The dose of omega-3 fatty acids depended on the weight of patients according to World Health Organization recommendations 400 milligrams per 10 kilograms of body weight and had been given into two doses per day, before morning and evening meals</description>
    <arm_group_label>non supplemented</arm_group_label>
    <arm_group_label>supplemented</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

        Children between 5 - 16 years old with diffusely hyper echogenic liver at ultrasonography
        were included in the study.

        Exclusion Criteria:

          -  Patients with secondary causes of steatosis including total parenteral nutrition,
             drugs causing fatty liver disease for example steroids, hepatitis A, B, C,
             cytomegalovirus, Epstein-Barr virus infections, autoimmune liver disease, metabolic
             liver diseases, Wilson's disease, and alpha-1-antitrypsin deficiency.

          -  Patients currently taking fish oil supplements.

          -  Patients with systemic illness such as cardiac and kidney diseases.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>6 Years</minimum_age>
    <maximum_age>16 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>zeinab Kabbany, professor</last_name>
    <role>Principal Investigator</role>
    <affiliation>Ain Shmas University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Pediatrics hospital Ain shams University</name>
      <address>
        <city>Cairo</city>
        <country>Egypt</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Egypt</country>
  </location_countries>
  <verification_date>February 2020</verification_date>
  <study_first_submitted>February 20, 2020</study_first_submitted>
  <study_first_submitted_qc>February 20, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">February 24, 2020</study_first_posted>
  <last_update_submitted>February 20, 2020</last_update_submitted>
  <last_update_submitted_qc>February 20, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">February 24, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Ain Shams University</investigator_affiliation>
    <investigator_full_name>yasmin gamal el gendy</investigator_full_name>
    <investigator_title>professor of pediatrics</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Fatty Liver</mesh_term>
    <mesh_term>Non-alcoholic Fatty Liver Disease</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

